Advisors Preferred’s MiMedx Group MDXG Stock Holding History

Advisors Preferred’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,558	Closed	-$42K	–	229
2018 Q2	$42K	Buy	+6,558	New	+$46.7K	0.02%	165

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Advisors Preferred's MDXG Position: Q3 2018 in Review

Advisors Preferred sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 6,558 shares — an estimated $42K sold.

Advisors Preferred first reported a position in MDXG in Q2 2018 and held it in 1 quarter. The position peaked at $42K in Q2 2018. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

Advisors Preferred reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
Advisors Preferred sold 6,558 MiMedx Group shares in Q3 2018, an estimated $42K.
Advisors Preferred first reported a position in MiMedx Group in Q2 2018 and held it in 1 quarter.
Advisors Preferred's MiMedx Group position peaked at $42K in Q2 2018.
186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on Advisors Preferred's 13F filing for Q3 2018, filed 25 Oct 2018.